Corvus Pharmaceuticals (CRVS) Interest & Investment Income (2015 - 2026)
Corvus Pharmaceuticals (CRVS) reported Interest & Investment Income of $2.05 million for Q2 2026, up 220.3% from $639,000 a year earlier and up 14.7% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Interest & Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Corvus Pharmaceuticals' Interest & Investment Income came in at $5.21 million, up 140.7% year-over-year; for FY2023, it was $1.58 million, up 142.2% from FY2022.
- Interest & Investment Income has a five-year compound annual growth rate of -7.0% (FY2018 to FY2023).
- By year, Interest & Investment Income came in at $654,000 in FY2022, -$15,000 in FY2021, $540,000 in FY2020 (-75.3%) and $2.18 million in FY2019 (-4.4%).
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q1 2015.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2023 (growth of 303.0%); the low point was Q1 2024 (a decline of 16.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | 2.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Sep 30, 2025 | 738,000.00 |
| Jun 30, 2025 | 639,000.00 |
| Mar 31, 2025 | 525,000.00 |
| Sep 30, 2024 | 566,000.00 |
| Jun 30, 2024 | 434,000.00 |
| Mar 31, 2024 | 316,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | 425,000.00 |
| Jun 30, 2023 | 403,000.00 |
| Mar 31, 2023 | 376,000.00 |
| Dec 31, 2022 | 318,000.00 |
| Sep 30, 2022 | 225,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | -8,000.00 |
| Sep 30, 2021 | -11,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 3,000.00 |
API Access
Corvus Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();